TPTX » Topics » TorreyPines Therapeutics To Present At The Thomas Weisel Partners 2006 Healthcare Conference

This excerpt taken from the TPTX 8-K filed Aug 30, 2006.

TorreyPines Therapeutics To Present At The Thomas Weisel Partners
2006 Healthcare Conference

SAN DIEGO, August 30, 2006 – TorreyPines Therapeutics, Inc. today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at the Thomas Weisel Partners 2006 Healthcare Conference in Boston on Wednesday, September 6th at 9:45 a.m., eastern.

On June 8, 2006, TorreyPines announced that it had entered into a definitive merger agreement with Axonyx Inc. (NASDAQ: AXYX). The resulting company will be named TorreyPines Therapeutics, Inc. and be headquartered in San Diego. The transaction is expected to close during the fourth quarter of this year. Upon closing, the company is expected to trade on the NASDAQ Stock Market for which the company has reserved the symbol “TPTX.” Dr. Kurtz will provide a brief overview of this transaction during his remarks.

A webcast of Dr. Kurtz’s presentation will be available live. You can access the webcast at: www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.

TorreyPines Therapeutics, Inc. is a biopharmaceutical company that discovers and develops small molecule drugs to treat diseases and disorders of the central nervous system. Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new therapies for migraine; chronic pain, including neuropathic pain; and cognitive disorders including Alzheimer’s disease. Its therapies are intended to offer meaningful advantages over currently marketed therapies. Further information is available at www.torreypinestherapeutics.com.

(more)



(TORREYPINES THERAPEUTICS LOGO)

Page 2

This excerpt taken from the TPTX DEFA14A filed Aug 30, 2006.

TorreyPines Therapeutics To Present At The Thomas Weisel Partners
2006 Healthcare Conference

SAN DIEGO, August 30, 2006 – TorreyPines Therapeutics, Inc. today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at the Thomas Weisel Partners 2006 Healthcare Conference in Boston on Wednesday, September 6th at 9:45 a.m., eastern.

On June 8, 2006, TorreyPines announced that it had entered into a definitive merger agreement with Axonyx Inc. (NASDAQ: AXYX). The resulting company will be named TorreyPines Therapeutics, Inc. and be headquartered in San Diego. The transaction is expected to close during the fourth quarter of this year. Upon closing, the company is expected to trade on the NASDAQ Stock Market for which the company has reserved the symbol “TPTX.” Dr. Kurtz will provide a brief overview of this transaction during his remarks.

A webcast of Dr. Kurtz’s presentation will be available live. You can access the webcast at: www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.

TorreyPines Therapeutics, Inc. is a biopharmaceutical company that discovers and develops small molecule drugs to treat diseases and disorders of the central nervous system. Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new therapies for migraine; chronic pain, including neuropathic pain; and cognitive disorders including Alzheimer’s disease. Its therapies are intended to offer meaningful advantages over currently marketed therapies. Further information is available at www.torreypinestherapeutics.com.

(more)



(TORREYPINES THERAPEUTICS LOGO)

Page 2

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki